APA استشهاد

Al Machot, E., Hoffmann, T., Lorenz, K., Khalili, I., & Noack, B. (2014). Clinical Outcomes after Treatment of Periodontal Intrabony Defects with Nanocrystalline Hydroxyapatite (Ostim) or Enamel Matrix Derivatives (Emdogain): A Randomized Controlled Clinical Trial. Hindawi Publishing Corporation.

استشهاد بنمط شيكاغو

Al Machot, Elyan, Thomas Hoffmann, Katrin Lorenz, Ihssan Khalili, و Barbara Noack. Clinical Outcomes After Treatment of Periodontal Intrabony Defects With Nanocrystalline Hydroxyapatite (Ostim) or Enamel Matrix Derivatives (Emdogain): A Randomized Controlled Clinical Trial. Hindawi Publishing Corporation, 2014.

MLA استشهاد

Al Machot, Elyan, et al. Clinical Outcomes After Treatment of Periodontal Intrabony Defects With Nanocrystalline Hydroxyapatite (Ostim) or Enamel Matrix Derivatives (Emdogain): A Randomized Controlled Clinical Trial. Hindawi Publishing Corporation, 2014.

تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.